| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |